Ben Jameson
By Ben
Umoja Biopharma to Unveil UB-VV500, First In Vivo BCMA × GPRC5D CAR T Therapy for Multiple Myeloma at ASGCT
Umoja Biopharma will present UB-VV500, the industry’s first in vivo CAR T therapy combining BCMA and GPRC5D targeting multiple myeloma, at the ASGCT annual meeting, highlighting its novel dual-antigen approach and planned poster data release.